July 18, 2012 – Market Watch
MiniVax, Inc., a company specializing in the development of treatments for opportunistic fungal and bacterial infections, announced Dr. Bruce Beutler as the most recent addition to its Scientific Advisory Board. Dr. Beutler has over 25 years of experience in immunology research and is currently Director of the Center for the Genetics of Host Defense at the University of Texas Southwestern Medical Center.
New technology revolutionizes DNA testing of sexual assault samples InnoGenomics SpermX™ delivers reliable results to solve sexual assault crimes NEW ORLEANS (March 28, 2023) – Addressing a long-term shortcoming in…
Local Biotech Company is Improving Clinical Care for Animals PetVet Dx celebrated recent expansion and future plans at a community event Friday NEW ORLEANS (March 31, 2023) Local biotech company…
The New Orleans BioInnovation Center Welcomes Program Director Muieen Cader to coordinate capital access & experiential learning programming NEW ORLEANS (Feb. 9, 2023) — The New Orleans BioInnovation Center…